Annals of Surgical Oncology

, Volume 10, Issue 10, pp 1171–1175 | Cite as

Long-Term Survival after Resection for Primary Hepatic Carcinoid Tumor

  • Clayton D. KnoxEmail author
  • Christopher D. Anderson
  • Laura W. Lamps
  • R. Benton Adkins
  • C. Wright Pinson
Original Articles


Background:Primary hepatic carcinoid tumors (PHCTs) are extremely rare, and fewer than 50 cases have been reported in the English-language literature. We report a patient with a PHCT and review the cases in the literature.

Methods:Our patient presented with symptoms and underwent liver resection for PHCT and regional lymph node metastasis. He underwent two more liver resections over the following 7 years for recurrent PHCT. Cases reported in the English-language literature were reviewed and survival analysis was performed with the Kaplan-Meier method. The survival impacts of age, gender, tumor foci, extrahepatic metastasis, unilobar versus bilobar disease, and type of preoperative treatment were determined by means of log-rank test.

Results:Our patient has been free of symptoms for 14 years of follow-up and free of disease for 8 years of follow-up. Forty-eight cases of PHCT were found in the literature, and 92% of these patients underwent resection. Actuarial 5- and 10-year survival for all patients was 78% and 59%, respectively, whereas for resected patients, 10-year survival was 68%. The administration of preoperative chemotherapy, radiation therapy, or chemoembolization did not impact survival, nor did age, gender, presence of extrahepatic metastasis, number of tumors, or distribution of the tumor within the liver.

Conclusions:Resection is the treatment of choice for PHCT and has provided favorable outcomes. Resection for PHCT can be performed in most patients and offers long-term survival.

Key Words

Carcinoid Liver Neuroendocrine neoplasm Primary Resection 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Staren ED, Gould VE, Warren WH, et al. Neuro-endocrine carcinomas of the colon and rectum: a clinicopathologic evaluation. Surgery 1988; 104: 1080–9.PubMedGoogle Scholar
  2. 2.
    Craig JR, Peters RL, Edmondson HA. Atlas of Tumor Pathology. Washington, DC: Armed Forces Institute of Pathology, 1989.Google Scholar
  3. 3.
    Modlin IM, Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer 1997; 79: 813–29.PubMedCrossRefGoogle Scholar
  4. 4.
    Moertel CG. Karnofsky memorial lecture: an odyssey in the land of small tumors. J Clin Oncol 1987; 5: 1502–22.PubMedGoogle Scholar
  5. 5.
    Shebani KO, Souba WW, Finkelstein DM, et al. Prognosis and survival in patients with gastrointestinal tract carcinoid tumors. Ann Surg 1999; 229: 815–21.PubMedCrossRefGoogle Scholar
  6. 6.
    Norheim I, Oberg K, Theodorsson-Norheim E, et al. Malignant carcinoid tumors: an analysis of 103 patients with regard to tumor localization, hormone production, and survival. Ann Surg 1987; 206: 115–25.PubMedCrossRefGoogle Scholar
  7. 7.
    Edmondson HA. Carcinoid tumor. In: Edmondson HA, ed. Tumors of the liver and intrahepatic bile ducts. Washington, DC: Armed Forces Institute of Pathology, 1958: 105–11.Google Scholar
  8. 8.
    Iwao M, Nakamuta M, Enjoji M, et al. Primary hepatic carcinoid tumor: case report and review of 53 cases. Med Sci Monit 2001; 7: 746–50.PubMedGoogle Scholar
  9. 9.
    Andreola S, Lombardi L, Audisio RA, et al. A clinicopathological study of primary hepatic carcinoid-tumors. Cancer 1990; 65: 1211–8.PubMedCrossRefGoogle Scholar
  10. 10.
    Aoki K, Sakamoto M, Mukai K, Kosuge T, Takayama T, Hirohashi S. Signet-ring cell carcinoid: a primary hepatic carcinoid-tumor with cytoplasmic inclusions comprising of aggregates of keratin. Jpn J Clin Oncol 1992; 22: 54–9.PubMedGoogle Scholar
  11. 11.
    Asakawa T, Tomioka T, Abe K, Yamaguchi T, Tsunoda T, Kanematsu T. Primary hepatic carcinoid tumor. J Gastroenterol 1999; 34: 123–7.PubMedCrossRefGoogle Scholar
  12. 12.
    Fujino K, Koito K, Sano S, et al. A primary hepatic carcinoid tumor: evaluation by computed tomography and magnetic resonance imaging. Radiat Med 1998; 16: 371–3.PubMedGoogle Scholar
  13. 13.
    Furrer J, Hattenschwiler A, Komminoth P, Pfammatter T, Wiesli P. Carcinoid syndrome, acromegaly, and hypoglycemia due to an insulin-secreting neuroendocrine tumor of the liver. J Clin Endocrinol Metab 2001; 86: 2227–30.PubMedCrossRefGoogle Scholar
  14. 14.
    Gould VE, Banner BF, Baerwaldt M. Neuroendocrine neoplasms in unusual primary sites. Diagn Histopathol 1981; 4: 263–77.PubMedGoogle Scholar
  15. 15.
    Hirata M, Ishida H, Konno K, et al. Primary carcinoid tumor of the liver: report of two cases with an emphasis on US findings. Abdom Imaging 2002; 27: 325–8.PubMedGoogle Scholar
  16. 16.
    Holbrook RF, Koo K, Ryan JA. Resection of malignant primary liver tumors. Am J Surg 1996; 171: 453–5.PubMedCrossRefGoogle Scholar
  17. 17.
    Iimuro Y, Deguchi Y, Ueda Y, et al. Primary hepatic carcinoid tumor with metachronous lymph node metastasis after long-term follow up. J Gastroenterol Hepatol 2002; 17: 1119–24.PubMedCrossRefGoogle Scholar
  18. 18.
    Imaoka I, Sugimura K, Tamura K. Case report: MR imaging of a carcinoid tumour of the liver. Clin Radiol 1993; 47: 287–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Inoue Y, Nakamura H, Mizumoto S, Mori H, Yamasaki K. Primary hepatic carcinoid with production of gastrin: a case report. Radiat Med 1993; 11: 102–6.PubMedGoogle Scholar
  20. 20.
    Johnson FD. Ectopic ACTH syndrome in APUD tumors. Oncology 1982; 39: 358–61.PubMedCrossRefGoogle Scholar
  21. 21.
    Kehagias D, Moulopoulos L, Smirniotis V, Pafiti A, Ispanopoulos S, Vlahos L. Imaging findings in primary carcinoid tumour of the liver with gastrin production. Br J Radiol 1999; 72: 207–9.PubMedGoogle Scholar
  22. 22.
    Krishnamurthy SC, Dutta V, Pai SA, et al. Primary carcinoid tumor of the liver: report of four resected cases including one with gastrin production. J Surg Oncol 1996; 62: 218–21.PubMedCrossRefGoogle Scholar
  23. 23.
    Mehta DC, Warner RRP, Parnes I, Weiss M. An 18-year follow-up of primary hepatic carcinoid with carcinoid syndrome. J Clin Gastroenterol 1996; 23: 60–2.PubMedCrossRefGoogle Scholar
  24. 24.
    Mizuno Y, Ohkohchi N, Fujimori K, et al. Primary hepatic carcinoid tumor: a case report. Hepatogastroenterology 2000; 47: 528–30.PubMedGoogle Scholar
  25. 25.
    Moriura S, Ikeda S, Hirai M, et al. Hepatic gastrinoma. Cancer 1993; 72: 1547–50.PubMedCrossRefGoogle Scholar
  26. 26.
    Oh YH, Kang GH, Kim OJ. Primary hepatic carcinoid tumor with a paranuclear clear zone: a case report. J Korean Med Sci 1998; 13: 317–20.PubMedGoogle Scholar
  27. 27.
    Pilichowska M, Kimura N, Ouchi A, Lin H, Mizuno Y, Nagura H. Primary hepatic carcinoid and neuroendocrine carcinoma: clinicopathological and immunohistochemical study of five cases. Pathology International 1999; 49: 318–24.PubMedCrossRefGoogle Scholar
  28. 28.
    Ruckert RI, Ruckert JC, Dorffel Y, Rudolph B, Muller JM. Primary hepatic neuroendocrine tumor: successful hepatectomy in two cases and review of the literature. Digestion 1999; 60: 110–6.PubMedCrossRefGoogle Scholar
  29. 29.
    Sano K, Kosuge T, Yamamoto J, et al. Primary hepatic carcinoid tumors confirmed with long-term follow-up after resection. Hepatogastroenterology 1999; 46: 2547–50.PubMedGoogle Scholar
  30. 30.
    Sioutos N, Virta S, Kessimian N. Primary hepatic carcinoid-tumor: an electron-microscopic and immunohistochemical study. Am J Clin Pathol 1991; 95: 172–5.PubMedGoogle Scholar
  31. 31.
    Smith AL, Auldist AW. Successful surgical resection of an hepatic gastrinoma in a child. J Pediatr Gastroenterol Nutrition 1984; 3: 801–4.Google Scholar
  32. 32.
    Takayasu K, Muramatsu Y, Sakamoto M, et al. Findings in primary hepatic carcinoid-tumor: US, CT, MRI, and angiography. J Comput Assisted Tomography 1992; 16: 99–102.CrossRefGoogle Scholar
  33. 33.
    Une Y, Li Y, Uemura K, et al. Primary hepatic carcinoid tumor: a case report and review of the literature. Oncology Rep 1996; 3: 1091–5.Google Scholar
  34. 34.
    Wang CY, Chen A, Tseng HH, Tu YC, Chen VT, Hsieh HF. Carcinoid tumor localized in the liver: two cases report. Immunohistochemical and ultrastructural studies. Zhonghua Yi Xue Za Zhi (Taipei) 1992; 49: 365–72.Google Scholar
  35. 35.
    Warner TF, Seo IS, Madura JA, Polak JM, Pearse AG. Pancreatic-polypeptide-producing apudoma of the liver. Cancer 1980; 46: 1146–51.PubMedCrossRefGoogle Scholar
  36. 36.
    Yasoshima H, Uematsu K, Sakurai K, et al. Primary hepatic carcinoid-tumor. Acta Pathologica Japonica 1993; 43: 783–9.PubMedGoogle Scholar
  37. 37.
    Miura K, Shirasawa H. Primary carcinoid-tumor of the liver. Am J Clin Pathol 1988; 89: 561–4.PubMedGoogle Scholar
  38. 38.
    Thompson NW, Vinik AI, Eckhauser FE, Strodel WE. Extrapancreatic gastrinomas. Surgery 1985; 98: 1113–20.PubMedGoogle Scholar
  39. 39.
    Skinazi F, Zins M, Menu Y, Bernades P, Ruszniewski P. Liver metastases of digestive endocrine tumours: natural history and response to medical treatment. Eur J Gastroenterol Hepatol 1996; 8: 673–8.PubMedGoogle Scholar
  40. 40.
    Soreide O, Berstad T, Bakka A, et al. Surgical treatment as a principle in patients with advanced abdominal carcinoid tumors. Surgery 1992; 111: 48–54.PubMedGoogle Scholar
  41. 41.
    Chen H, Hardacre JM, Uzar A, Cameron JL, Choti MA. Isolated liver metastases from neuroendocrine tumors: does resection prolong survival? J Am Coll Surg 1998; 187: 88–92.PubMedCrossRefGoogle Scholar
  42. 42.
    Yao KA, Talamonti MS, Nemcek A, et al. Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors. Surgery 2001; 130: 677–82.PubMedCrossRefGoogle Scholar
  43. 43.
    Wangberg B, Westberg G, Tylen U, et al. Survival of patients with disseminated midgut carcinoid tumors after aggressive tumor reduction. World J Surg 1996; 20: 892–9.PubMedCrossRefGoogle Scholar
  44. 44.
    Que FG, Nagorney DM, Batts KP, Linz LJ, Kvols LK, Hepatic resection for metastatic neuroendocrine carcinomas. Am J Surg 1995; 169: 36–42.PubMedCrossRefGoogle Scholar
  45. 45.
    McEntee GP, Nagorney DM, Kvols LK, Moertel CG, Grant CS. Cytoreductive hepatic surgery for neuroendocrine tumors. Surgery 1990; 108: 1091–6.PubMedGoogle Scholar
  46. 46.
    Kirshbom PM, Tyler DS. Malignant Liver Tumors: Current and Emerging Therapies. Malden, MA: Blackwell Sciences, 1999.Google Scholar

Copyright information

© The Society of Surgical Oncology, Inc. 2003

Authors and Affiliations

  • Clayton D. Knox
    • 1
    • 2
    Email author
  • Christopher D. Anderson
    • 1
  • Laura W. Lamps
    • 2
  • R. Benton Adkins
    • 1
  • C. Wright Pinson
    • 1
  1. 1.Department of SurgeryVanderbilt University Medical CenterNashville
  2. 2.Department of PathologyVanderbilt University Medical CenterNashville

Personalised recommendations